Editorial: Muscular dystrophies: Current therapeutic advances to improve and restore muscle homeostasis

Editorial: Muscular dystrophies: Current therapeutic advances to improve and restore muscle homeostasis

Bibliographic Details
Main Authors:	Ariadna Bargiela, Francisco Hernández-Torres
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	muscular stem cells muscular dystrophies regeneration therapy muscle differentiation
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2022.1009439/full

Similar Items

MiRNAs and Muscle Regeneration: Therapeutic Targets in Duchenne Muscular Dystrophy
by: Amelia Eva Aránega, et al.
Published: (2021-04-01)

Implications of notch signaling in duchenne muscular dystrophy
by: Lily Den Hartog, et al.
Published: (2022-09-01)

A FRAMEWORK FOR PSYCHOLOGICAL MANAGEMENT OF INDIVIDUALS WITH MUSCULAR DYSTROPHY /
by: Elna Herawati Che Ismail, author 654886, et al.
Published: (2022)

A FRAMEWORK FOR PSYCHOLOGICAL MANAGEMENT OF INDIVIDUALS WITH MUSCULAR DYSTROPHY /
by: Elna Herawati Che Ismail, author 654886, et al.
Published: (2022)

Inducible Heat Shock Protein 70 Levels in Patients and the mdx Mouse Affirm Regulation during Skeletal Muscle Regeneration in Muscular Dystrophy
by: Gwenny Cosemans, et al.
Published: (2022-07-01)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

Muscular Dystrophy /
by: Naff, Clay Farris, editor 192865, et al.
Published: (2012)

A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01)

Muscle Magnetic Resonance Imaging in Patients with Various Clinical Subtypes of LMNA-Related Muscular Dystrophy
by: Hui-Ting Lin, et al.
Published: (2018-01-01)

Current Pharmacological Strategies for Duchenne Muscular Dystrophy
by: Shanshan Yao, et al.
Published: (2021-08-01)

Angiogenesis as a novel therapeutic strategy for Duchenne muscular dystrophy through decreased ischemia and increased satellite cells
by: Yuko eShimizu-Motohashi, et al.
Published: (2014-02-01)

Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies
by: Martina Sandonà, et al.
Published: (2023-02-01)

Gpr18 agonist dampens inflammation, enhances myogenesis, and restores muscle function in models of Duchenne muscular dystrophy
by: Junio Dort, et al.
Published: (2023-08-01)

Timed immersion expiration measures in patients with muscular dystrophies
by: Mariana Callil Voos, et al.
Published: (2020-02-01)

“The Social Network” and Muscular Dystrophies: The Lesson Learnt about the Niche Environment as a Target for Therapeutic Strategies
by: Ornella Cappellari, et al.
Published: (2020-07-01)

Motor clinical progression in a series of pediatric Duchenne and Becker muscular dystrophy cases
by: Zakiah Nur Istianah, et al.
Published: (2019-03-01)

Duchenne and Becker muscular dystrophy in adolescents: current perspectives
by: Andrews JG, et al.
Published: (2018-03-01)

Prevalence of muscular dystrophy in patients with muscular disorders in Tehran, Iran
by: Khadijeh Hajinaghi Tehrani, et al.
Published: (2018-05-01)

Influence of <i>DUX4</i> Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments
by: Elisa Duranti, et al.
Published: (2023-05-01)

Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy
by: Pamela Bella, et al.
Published: (2020-01-01)

Satellite cell contribution to disease pathology in Duchenne muscular dystrophy
by: Kasun Kodippili, et al.
Published: (2023-05-01)

Oculopharyngeal muscular dystrophy - an under-diagnosed disorder?
by: M Plasilov, et al.
Published: (2005-10-01)

Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies
by: Elena Abati, et al.
Published: (2021-09-01)

Detection of the mutation may guide treatment of heart and muscle in Duchenne muscular dystrophy
by: Finsterer J, et al.
Published: (2016-03-01)

Duchenne muscular dystrophy: Genetic and clinical profile in the population of Rajasthan, India
by: Manisha Goyal, et al.
Published: (2021-01-01)

The association of hand grip strength with functional measures in non-ambulatory children with Duchenne muscular dystrophy
by: Numan Bulut, et al.
Published: (2019-12-01)

Molecular targets to treat muscular dystrophies
by: Jochen Kinter, et al.
Published: (2014-02-01)

Research advance and application prospect of therapeutic strategies for Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2018-07-01)

Preserved thenar muscles in non‐ambulant Duchenne muscular dystrophy patients
by: Karin J. Naarding, et al.
Published: (2021-06-01)

Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models
by: Kyra K. Peczkowski, et al.
Published: (2020-09-01)

Role of Insulin-Like Growth Factor Receptor 2 across Muscle Homeostasis: Implications for Treating Muscular Dystrophy
by: Yvan Torrente, et al.
Published: (2020-02-01)

Errata: Measuring Disease Severity in Duchenne and Becker Muscular Dystrophy
by: Melinda F. Davis, et al.
Published: (2011-05-01)

Modified transfer of the pectoralis major muscle for restoration of elbow flexion in facioscapulohumeral muscular dystrophy: A case report
by: Joong-Bae Seo, et al.
Published: (2024-03-01)

Evaluation of pro-regenerative and anti-inflammatory effects of isolecanoric acid in the muscle: Potential treatment of Duchenne Muscular Dystrophy
by: Lidia Matias-Valiente, et al.
Published: (2024-01-01)

Corrigendum: Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models
by: Kyra K. Peczkowski, et al.
Published: (2022-01-01)

Myopathologic trajectory in Duchenne muscular dystrophy (DMD) reveals lack of regeneration due to senescence in satellite cells
by: Nastasia Cardone, et al.
Published: (2023-10-01)

Pharyngeal pathology in a mouse model of oculopharyngeal muscular dystrophy is associated with impaired basal autophagy in myoblasts
by: Yu Zhang, et al.
Published: (2022-10-01)

The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy
by: Caroline Merckx, et al.
Published: (2022-02-01)

Inflammasome Activity in the Skeletal Muscle and Heart of Rodent Models for Duchenne Muscular Dystrophy
by: Zsófia Onódi, et al.
Published: (2023-05-01)

Flavonoids and Omega3 Prevent Muscle and Cardiac Damage in Duchenne Muscular Dystrophy Animal Model
by: Luana Tripodi, et al.
Published: (2021-10-01)